| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V118703 | Morpholino T phosphoramidite | 1037305-43-3 | Morpholino-T phosphoramide is a nucleoside building block commonly used to construct morpholino oligonucleotides. |
|
V116682 | Mouse CB10 of type II collagen | Mouse type II collagen CB10 (mouse cyanogen bromide digested peptide 10) is a cyanogen bromide digested peptide (CB peptide) fragment of type II collagen, which can be used to study B cell and T cell epitopes of type II collagen. | |
|
V116695 | Mouse CB11 of type II collagen | Mouse type II collagen CB11 (mouse cyanogen bromide digested peptide 11) is a cyanogen bromide digested peptide (CB peptide) of type II collagen, which can be used to study B cell and T cell epitopes of type II collagen. | |
|
V116552 | Mouse CB8 of type II collagen | Mouse type II collagen CB8 (mouse cyanogen bromide digested peptide 8) is a cyanogen bromide digested peptide (CB peptide) fragment of type II collagen, which can be used to study B cell and T cell epitopes of type II collagen. | |
|
V117307 | Mouse Immunoglobulin G1 | Mouse immunoglobulin G1 is a mouse serum immunoglobulin that can be used as an immunomarker and coating protein in various immunoassays, including ELISA. | |
|
V117331 | Mouse Immunoglobulin G2a | Mouse immunoglobulin G2a is a mouse serum immunoglobulin that can be used as an immunomarker and coating protein in various immunoassays, including ELISA. | |
|
V117379 | Mouse Immunoglobulin G2b | Mouse immunoglobulin G2b is a mouse serum immunoglobulin that can be used as an immunomarker and coating protein in various immunoassays, including ELISA. | |
|
V106110 | Mouse Laminin | Mouse Laminin is a laminin protein derived from mouse that can be used as a thin coating on tissue culture surfaces or as a soluble additive to culture media. | |
|
V108964 | mPEG-Amide-tri(DPCA) | 2459303-76-3 | mPEG-Amide-tri(DPCA) is a PEG-DPCA conjugate that can self-assemble with PEG-DPCA conjugate 1 to form a supramolecular polymer hydrogel with a nanofiber structure. |
|
V90283 | mPEG-Epoxide | mPEG-Epoxide is an activated polyethylene glycol (mPEG) derivative that is created by converting the hydroxyl groups of mPEG into reactive epoxy groups. | |
|
V65942 | mPEG-Mal (MW 750) (mPEG-Maleimide (MW 750); Methoxypolyethylene glycol maleimide (MW 750)) | 724722-89-8 | mPEG-Mal (MW 750) is a PEG analogue used for thiol pegylation of protein molecules. |
|
V80832 | MPEG-PLA (PEG MW 3000 & PLA MW 50,000) | MPEG-PLA (PEG MW 3000 & PLA MW 50,000) is a block copolymer that may be utilized to prepare nanoparticles for targeted drug delivery. | |
|
V102403 | mPEG-PLGA (2000-80000) (LA/GA 50:50) | mPEG-PLGA (2000-80000) (LA/GA 50:50) is a copolymer composed of hydrophilic mPEG and biodegradable PLGA (molar ratio of 50:50), with a molecular weight of 2000 (mPEG) + 80000 (PLGA). | |
|
V92462 | mPEG-PLGA (21500-26500) | 743423-15-6 | mPEG-PLGA (21500-26500) is a biodegradable polymer composed of methyl polyethylene glycol (mPEG) and poly(lactic-co-glycolic acid) (PLGA). |
|
V101493 | mPEG-PLLA | mPEG-PLLA is a diblock copolymer. | |
|
V80836 | mRNA Cap 2'-O-methyltransferase | mRNA Cap 2'-O-methyltransferase uses S-adenosylmethionine (SAM) as a methyl donor to add a 2'-O position at the first nucleotide at the 5' end of Cap-0 mRNA Methyl group, forming the Cap-1 structure. | |
|
V65987 | mRNA-Encapsulating Lipid Excipient 1 | 2230647-37-5 | mRNA-Encapsulating Lipid Excipient 1 (Compound 2) is a thiocarbamate-based ionizable lipid. |
|
V119524 | MS 1 | 96552-95-3 | MS 1 (Momordica cochinchinensis saponin I) is a vaccine adjuvant found in the seeds of the perennial bitter gourd (Momordica cochinchinensis Spreng). |
|
V119764 | MS 2 | 96552-96-4 | MS 2 (momordica saponin II) is a vaccine adjuvant found in the seeds of the perennial bitter gourd (Momordica cochinchinensis Spreng). |
|
V115041 | MS Medium (Agar-Free) | MS medium (agar-free) is a medium with a high concentration of inorganic salts and ions, making it a relatively stable equilibrium solution. |